SG Americas Securities’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$200M Buy
1,665,520
+274,129
+20% +$31.6M 0.22% 75
2025
Q4
$146M Buy
1,391,391
+148,288
+12% +$13.9M 0.19% 80
2025
Q3
$104M Buy
1,243,103
+1,033,828
+494% +$85.2M 0.35% 34
2025
Q2
$16.6M Sell
209,275
-451,420
-68% -$35.9M 0.07% 210
2025
Q1
$59.3M Buy
660,695
+579,196
+711% +$54.1M 0.19% 66
2024
Q4
$8.11M Buy
81,499
+15,982
+24% +$1.65M 0.03% 258
2024
Q3
$7.44M Sell
65,517
-971,844
-94% -$115M 0.03% 322
2024
Q2
$128M Buy
1,037,361
+942,887
+998% +$121M 0.75% 18
2024
Q1
$12.5M Sell
94,474
-20,309
-18% -$2.5M 0.06% 312
2023
Q4
$12.5M Sell
114,783
-85,919
-43% -$8.92M 0.12% 165
2023
Q3
$20.7M Buy
200,702
+127,396
+174% +$13.7M 0.24% 68
2023
Q2
$8.46M Buy
73,306
+41,480
+130% +$4.71M 0.06% 215
2023
Q1
$3.39M Buy
31,826
+13,580
+74% +$1.47M 0.04% 414
2022
Q4
$2.02M Sell
18,246
-41,365
-69% -$4.23M 0.02% 555
2022
Q3
$5.13M Sell
59,611
-34,605
-37% -$3.09M 0.06% 256
2022
Q2
$8.59M Buy
94,216
+48,668
+107% +$4.31M 0.09% 175
2022
Q1
$3.74M Sell
45,548
-214,493
-82% -$16.9M 0.03% 558
2021
Q4
$19.9M Buy
260,041
+236,869
+1,022% +$18.9M 0.11% 140
2021
Q3
$1.74M Sell
23,172
-613,971
-96% -$46.7M 0.01% 1403
2021
Q2
$49.6M Sell
637,143
-33,083
-5% -$2.46M 0.23% 68
2021
Q1
$49.3M Buy
670,226
+431,412
+181% +$31.8M 0.26% 65
2020
Q4
$18.6M Buy
238,814
+119,813
+101% +$9.16M 0.1% 157
2020
Q3
$9.42M Sell
119,001
-153,590
-56% -$12M 0.06% 203
2020
Q2
$20.1M Buy
272,591
+102,743
+60% +$7.73M 0.17% 98
2020
Q1
$12.5M Buy
169,848
+91,849
+118% +$7.22M 0.12% 150
2019
Q4
$6.77M Sell
77,999
-52,818
-40% -$4.34M 0.06% 291
2019
Q3
$10.5M Sell
130,817
-685,587
-84% -$54.9M 0.09% 235
2019
Q2
$65.3M Buy
816,404
+577,375
+242% +$44.2M 0.45% 36
2019
Q1
$19M Sell
239,029
-5,378
-2% -$402K 0.17% 124
2018
Q4
$17.8M Sell
244,407
-137,617
-36% -$9.71M 0.16% 120
2018
Q3
$25.9M Buy
382,024
+116,433
+44% +$7.42M 0.19% 102
2018
Q2
$15.4M Sell
265,591
-841,573
-76% -$47.5M 0.14% 149
2018
Q1
$57.5M Buy
1,107,164
+564,182
+104% +$30.5M 0.46% 31
2017
Q4
$29.2M Buy
542,982
+326,965
+151% +$18.1M 0.27% 51
2017
Q3
$13.2M Sell
216,017
-341,196
-61% -$20.7M 0.12% 120
2017
Q2
$34.1M Sell
557,213
-323,444
-37% -$19.7M 0.31% 59
2017
Q1
$53.4M Sell
880,657
-627,694
-42% -$38.1M 0.47% 40
2016
Q4
$84.7M Buy
1,508,351
+1,497,424
+13,704% +$87.6M 0.71% 21
2016
Q3
$651K Sell
10,927
-34,913
-76% -$2.04M 0.01% 1490
2016
Q2
$2.52M Sell
45,840
-112,407
-71% -$5.98M 0.02% 716
2016
Q1
$7.99M Sell
158,247
-350,924
-69% -$17.2M 0.06% 261
2015
Q4
$25.7M Sell
509,171
-3,822,175
-88% -$193M 0.18% 95
2015
Q3
$86.4M Buy
4,331,346
+3,743,124
+636% +$199M 0.52% 34
2015
Q2
$32M Sell
588,222
-433,312
-42% -$24.3M 0.21% 73
2015
Q1
$56M Sell
1,021,534
-1,773,988
-63% -$100M 0.33% 56
2014
Q4
$151M Buy
2,795,522
+561,909
+25% +$31.3M 0.74% 24
2014
Q3
$126M Buy
2,233,613
+982,657
+79% +$55.2M 0.74% 19
2014
Q2
$69.1M Sell
1,250,956
-1,058,427
-46% -$57.7M 0.4% 45
2014
Q1
$125M Sell
2,309,383
-260,395
-10% -$13.5M 0.54% 27
2013
Q4
$123M Buy
2,569,778
+333,770
+15% +$15.3M 0.51% 32
2013
Q3
$102M Sell
2,236,008
-67,644
-3% -$3.09M 0.42% 50
2013
Q2
$102M Buy
+2,303,652
New +$103M 0.5% 38

Other funds holding MRK

SG Americas Securities's MRK Position: Q1 2026 in Review

SG Americas Securities increased its Merck (MRK) stake by 20% in Q1 2026, buying an estimated $31.6M and bringing the position to 1,665,520 shares worth $200M. The position accounts for 0.22% of the portfolio, ranked #75.

SG Americas Securities first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • SG Americas Securities held 1,665,520 shares of Merck worth $200M as of Q1 2026.
  • SG Americas Securities bought 274,129 Merck shares in Q1 2026, an estimated $31.6M.
  • Merck made up 0.22% of SG Americas Securities's portfolio in Q1 2026, its #75 holding.
  • SG Americas Securities first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.